Parent, Guarantor, Non-Guarantor Unaudited Consolidating Condensed Financial Statements - Consolidated Condensed Statements of Cash Flows (Detail) - USD ($)
$ in Thousands |
3 Months Ended |
9 Months Ended |
Sep. 30, 2016 |
Sep. 30, 2015 |
Sep. 30, 2016 |
Sep. 30, 2015 |
| Cash flows from operating activities: |
|
|
|
|
| Net income (loss) |
$ (46,228)
|
$ (48,482)
|
$ (181,885)
|
$ (58,638)
|
| Adjustments to reconcile net income (loss) |
|
|
|
|
| Depreciation and amortization |
34,474
|
39,584
|
106,605
|
118,474
|
| Accretion of contingent consideration |
|
|
419
|
547
|
| Provision for reduction in carrying value of certain assets |
0
|
906
|
0
|
3,222
|
| Loss on debt modification |
|
|
1,088
|
0
|
| (Gain) loss on disposition of assets |
187
|
(383)
|
249
|
(2,686)
|
| Deferred income tax expense (benefit) |
|
|
61,199
|
10,259
|
| Expenses not requiring cash |
|
|
(4,031)
|
8,029
|
| Equity in net earnings of subsidiaries |
0
|
0
|
0
|
0
|
| Accounts and notes receivable |
|
|
44,799
|
51,254
|
| Other assets |
|
|
3,282
|
1,486
|
| Accounts payable and accrued liabilities |
|
|
(30,590)
|
(15,790)
|
| Accrued income taxes |
|
|
(1,992)
|
(7,305)
|
| Net cash provided by operating activities |
|
|
(857)
|
108,852
|
| Cash flows from investing activities: |
|
|
|
|
| Capital expenditures |
|
|
(20,994)
|
(72,469)
|
| Proceeds from the sale of assets |
|
|
2,296
|
731
|
| Proceeds from insurance settlements |
|
|
0
|
2,500
|
| Acquisition, net of cash acquired |
|
|
0
|
(10,431)
|
| Net cash used in investing activities |
|
|
(18,698)
|
(79,669)
|
| Cash flows from financing activities: |
|
|
|
|
| Repayments of long-term debt |
|
|
|
(30,000)
|
| Paydown on term note |
|
|
0
|
(30,000)
|
| Payment of debt issuance costs |
|
|
0
|
(1,996)
|
| Payment for noncontrolling interest |
|
|
(3,375)
|
0
|
| Payments of contingent consideration |
|
|
(6,000)
|
0
|
| Excess tax benefit from stock-based compensation |
|
|
(1,751)
|
(992)
|
| Intercompany advances, net |
|
|
0
|
0
|
| Net cash used in financing activities |
|
|
(11,126)
|
(32,988)
|
| Net increase (decrease) in cash and cash equivalents |
|
|
(30,681)
|
(3,805)
|
| Cash and cash equivalents, beginning of year |
|
104,651
|
134,294
|
108,456
|
| Cash and cash equivalents, end of period |
103,613
|
|
103,613
|
|
| Parent [Member] |
|
|
|
|
| Cash flows from operating activities: |
|
|
|
|
| Net income (loss) |
(46,228)
|
(48,620)
|
(181,885)
|
(59,427)
|
| Adjustments to reconcile net income (loss) |
|
|
|
|
| Depreciation and amortization |
0
|
0
|
0
|
0
|
| Accretion of contingent consideration |
|
|
0
|
0
|
| Provision for reduction in carrying value of certain assets |
0
|
|
|
0
|
| Loss on debt modification |
|
|
1,088
|
|
| (Gain) loss on disposition of assets |
0
|
0
|
0
|
0
|
| Deferred income tax expense (benefit) |
|
|
46,773
|
(24,184)
|
| Expenses not requiring cash |
|
|
4,155
|
6,498
|
| Equity in net earnings of subsidiaries |
24,887
|
29,913
|
65,679
|
29,316
|
| Accounts and notes receivable |
|
|
0
|
(33)
|
| Other assets |
|
|
(113,372)
|
(121,465)
|
| Accounts payable and accrued liabilities |
|
|
(7,079)
|
(10,480)
|
| Accrued income taxes |
|
|
33,313
|
6,481
|
| Net cash provided by operating activities |
|
|
(151,328)
|
(173,294)
|
| Cash flows from investing activities: |
|
|
|
|
| Capital expenditures |
|
|
0
|
0
|
| Proceeds from the sale of assets |
|
|
0
|
0
|
| Proceeds from insurance settlements |
|
|
|
0
|
| Acquisition, net of cash acquired |
|
|
|
0
|
| Net cash used in investing activities |
|
|
0
|
0
|
| Cash flows from financing activities: |
|
|
|
|
| Repayments of long-term debt |
|
|
|
(30,000)
|
| Payment of debt issuance costs |
|
|
|
(1,996)
|
| Payment for noncontrolling interest |
|
|
(3,375)
|
|
| Payments of contingent consideration |
|
|
0
|
|
| Excess tax benefit from stock-based compensation |
|
|
(1,751)
|
(992)
|
| Intercompany advances, net |
|
|
136,511
|
216,082
|
| Net cash used in financing activities |
|
|
131,385
|
183,094
|
| Net increase (decrease) in cash and cash equivalents |
|
|
(19,943)
|
9,800
|
| Cash and cash equivalents, beginning of year |
|
|
73,985
|
36,728
|
| Cash and cash equivalents, end of period |
54,042
|
|
54,042
|
|
| Guarantor [Member] |
|
|
|
|
| Cash flows from operating activities: |
|
|
|
|
| Net income (loss) |
(18,409)
|
(4,119)
|
(49,224)
|
(8,984)
|
| Adjustments to reconcile net income (loss) |
|
|
|
|
| Depreciation and amortization |
22,300
|
24,002
|
68,739
|
71,270
|
| Accretion of contingent consideration |
|
|
419
|
0
|
| Provision for reduction in carrying value of certain assets |
0
|
920
|
|
920
|
| Loss on debt modification |
|
|
0
|
|
| (Gain) loss on disposition of assets |
12
|
(407)
|
(141)
|
(452)
|
| Deferred income tax expense (benefit) |
|
|
12,693
|
10,032
|
| Expenses not requiring cash |
|
|
(505)
|
2,677
|
| Equity in net earnings of subsidiaries |
0
|
0
|
0
|
0
|
| Accounts and notes receivable |
|
|
26,956
|
36,694
|
| Other assets |
|
|
119,703
|
110,017
|
| Accounts payable and accrued liabilities |
|
|
(16,486)
|
(168)
|
| Accrued income taxes |
|
|
(27,191)
|
(2,081)
|
| Net cash provided by operating activities |
|
|
134,963
|
219,925
|
| Cash flows from investing activities: |
|
|
|
|
| Capital expenditures |
|
|
(10,121)
|
(50,396)
|
| Proceeds from the sale of assets |
|
|
435
|
489
|
| Proceeds from insurance settlements |
|
|
|
0
|
| Acquisition, net of cash acquired |
|
|
|
(10,431)
|
| Net cash used in investing activities |
|
|
(9,686)
|
(60,338)
|
| Cash flows from financing activities: |
|
|
|
|
| Repayments of long-term debt |
|
|
|
0
|
| Payment of debt issuance costs |
|
|
|
0
|
| Payment for noncontrolling interest |
|
|
0
|
|
| Payments of contingent consideration |
|
|
(6,000)
|
|
| Excess tax benefit from stock-based compensation |
|
|
0
|
0
|
| Intercompany advances, net |
|
|
(119,447)
|
(165,133)
|
| Net cash used in financing activities |
|
|
(125,447)
|
(165,133)
|
| Net increase (decrease) in cash and cash equivalents |
|
|
(170)
|
(5,546)
|
| Cash and cash equivalents, beginning of year |
|
|
13,854
|
13,546
|
| Cash and cash equivalents, end of period |
13,684
|
|
13,684
|
|
| Non-Guarantor [Member] |
|
|
|
|
| Cash flows from operating activities: |
|
|
|
|
| Net income (loss) |
(6,478)
|
(25,656)
|
(16,455)
|
(19,543)
|
| Adjustments to reconcile net income (loss) |
|
|
|
|
| Depreciation and amortization |
12,174
|
15,582
|
37,866
|
47,204
|
| Accretion of contingent consideration |
|
|
0
|
547
|
| Provision for reduction in carrying value of certain assets |
0
|
(14)
|
|
2,302
|
| Loss on debt modification |
|
|
0
|
|
| (Gain) loss on disposition of assets |
175
|
24
|
390
|
(2,234)
|
| Deferred income tax expense (benefit) |
|
|
1,733
|
24,411
|
| Expenses not requiring cash |
|
|
(7,681)
|
(1,146)
|
| Equity in net earnings of subsidiaries |
0
|
0
|
0
|
0
|
| Accounts and notes receivable |
|
|
17,843
|
14,593
|
| Other assets |
|
|
(3,049)
|
12,934
|
| Accounts payable and accrued liabilities |
|
|
(7,025)
|
(5,142)
|
| Accrued income taxes |
|
|
(8,114)
|
(11,705)
|
| Net cash provided by operating activities |
|
|
15,508
|
62,221
|
| Cash flows from investing activities: |
|
|
|
|
| Capital expenditures |
|
|
(10,873)
|
(22,073)
|
| Proceeds from the sale of assets |
|
|
1,861
|
242
|
| Proceeds from insurance settlements |
|
|
|
2,500
|
| Acquisition, net of cash acquired |
|
|
|
0
|
| Net cash used in investing activities |
|
|
(9,012)
|
(19,331)
|
| Cash flows from financing activities: |
|
|
|
|
| Repayments of long-term debt |
|
|
|
0
|
| Payment of debt issuance costs |
|
|
|
0
|
| Payment for noncontrolling interest |
|
|
0
|
|
| Payments of contingent consideration |
|
|
0
|
|
| Excess tax benefit from stock-based compensation |
|
|
0
|
0
|
| Intercompany advances, net |
|
|
(17,064)
|
(50,949)
|
| Net cash used in financing activities |
|
|
(17,064)
|
(50,949)
|
| Net increase (decrease) in cash and cash equivalents |
|
|
(10,568)
|
(8,059)
|
| Cash and cash equivalents, beginning of year |
|
|
46,455
|
58,182
|
| Cash and cash equivalents, end of period |
35,887
|
|
35,887
|
|
| Consolidation, Eliminations [Member] |
|
|
|
|
| Cash flows from operating activities: |
|
|
|
|
| Net income (loss) |
24,887
|
29,913
|
65,679
|
29,316
|
| Adjustments to reconcile net income (loss) |
|
|
|
|
| Depreciation and amortization |
0
|
0
|
0
|
0
|
| Accretion of contingent consideration |
|
|
0
|
0
|
| Provision for reduction in carrying value of certain assets |
0
|
|
|
0
|
| Loss on debt modification |
|
|
0
|
|
| (Gain) loss on disposition of assets |
0
|
0
|
0
|
0
|
| Deferred income tax expense (benefit) |
|
|
0
|
0
|
| Expenses not requiring cash |
|
|
0
|
0
|
| Equity in net earnings of subsidiaries |
(24,887)
|
$ (29,913)
|
(65,679)
|
(29,316)
|
| Accounts and notes receivable |
|
|
0
|
0
|
| Other assets |
|
|
0
|
0
|
| Accounts payable and accrued liabilities |
|
|
0
|
0
|
| Accrued income taxes |
|
|
0
|
0
|
| Net cash provided by operating activities |
|
|
0
|
0
|
| Cash flows from investing activities: |
|
|
|
|
| Capital expenditures |
|
|
0
|
0
|
| Proceeds from the sale of assets |
|
|
0
|
0
|
| Proceeds from insurance settlements |
|
|
|
0
|
| Acquisition, net of cash acquired |
|
|
|
0
|
| Net cash used in investing activities |
|
|
0
|
0
|
| Cash flows from financing activities: |
|
|
|
|
| Repayments of long-term debt |
|
|
|
0
|
| Payment of debt issuance costs |
|
|
|
0
|
| Payment for noncontrolling interest |
|
|
0
|
|
| Payments of contingent consideration |
|
|
0
|
|
| Excess tax benefit from stock-based compensation |
|
|
0
|
0
|
| Intercompany advances, net |
|
|
0
|
0
|
| Net cash used in financing activities |
|
|
0
|
0
|
| Net increase (decrease) in cash and cash equivalents |
|
|
0
|
0
|
| Cash and cash equivalents, beginning of year |
|
|
0
|
$ 0
|
| Cash and cash equivalents, end of period |
$ 0
|
|
$ 0
|
|